- About
- Projects
- Column 1
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
- Food & Nutrition
- Column 2
- Column 1
- News and Events
- Expanded Access eRequest
Public Meeting: Mitigating Risks from Human Xylazine Exposure
Mitigating Risks from Human Xylazine Exposure
Public Meeting: In-person and Virtual
October 4, 2023 | 9:15 am-5 pm (eastern)
The Foundation partnered with the Food and Drug Administration (FDA) to host "Mitigating Risks from Human Xylazine Exposure," a day-long meeting with both in-person and virtual attendance.
FDA Issues Warning Letters to Three Infant Formula Manufacturers - Associated Press Online
Today, the U.S. Food and Drug Administration issued warning letters to three infant formula manufacturers as part of the agency’s ongoing commitment to enhance regulatory oversight to help ensure that the industry is producing infant formula under the safest conditions possible.